Rankings
▼
Calendar
MDGL (Madrigal Pharmaceuticals, Inc.) Stock Financials & Earnings | Market Cap Arena
MDGL
Madrigal Pharmaceuticals, Inc.
Mkt Cap
$10B
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$958M
Net Income (TTM)
-$288M
EPS (TTM)
-$12.87
Free Cash Flow (TTM)
-$190M
Gross Margin
94.1%
Op. Margin
-31.3%
Net Margin
-30.1%
FCF Margin
-19.8%
P/S Ratio (TTM)
10.4x
P/E Ratio (TTM)
—
YoY Rev Growth
+432.1%
Employees
—
Earnings Reports
▶
Q4 2025
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$0
$0
-$78M
Q2 23
$0
$0
-$86M
Q3 23
$0
$0
-$99M
Q4 23
$0
$0
-$117M
Q1 24
$0
$0
-$152M
Q2 24
$15M
$14M
-$163M
Q3 24
$62M
$60M
-$116M
Q4 24
$103M
$100M
-$67M
Q1 25
$137M
$133M
-$79M
Q2 25
$213M
$204M
-$47M
Q3 25
$287M
$269M
-$114M
Q4 25
$321M
$297M
-$60M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
—
—
Q2 23
—
—
Q3 23
—
—
Q4 23
—
—
Q1 24
—
—
Q2 24
681.7x
—
Q3 24
129.9x
—
Q4 24
55.4x
—
Q1 25
31.4x
—
Q2 25
19.4x
—
Q3 25
13.5x
—
Q4 25
10.4x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$84M
-$84M
Q2 23
-$75M
-$75M
Q3 23
-$85M
-$85M
Q4 23
-$80M
-$81M
Q1 24
-$149M
-$150M
Q2 24
-$135M
-$140M
Q3 24
-$67M
-$68M
Q4 24
-$104M
-$105M
Q1 25
-$89M
-$89M
Q2 25
-$47M
-$47M
Q3 25
$80M
$79M
Q4 25
-$133M
-$133M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$35K
Q2 23
$69K
Q3 23
$339K
Q4 23
$1M
Q1 24
$357K
Q2 24
$5M
Q3 24
$779K
Q4 24
$195K
Q1 25
$0
Q2 25
$0
Q3 25
$857K
Q4 25
$390K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
—
+36.0%
Q2 23
—
+23.0%
Q3 23
—
+22.5%
Q4 23
—
+37.4%
Q1 24
—
+94.1%
Q2 24
—
+104.9%
Q3 24
—
+81.1%
Q4 24
—
+45.4%
Q1 25
—
+42.4%
Q2 25
+1353.8%
+46.7%
Q3 25
+362.0%
+124.8%
Q4 25
+210.8%
+123.5%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$11M
—
Q2 23
$11M
—
Q3 23
$13M
—
Q4 23
$15M
—
Q1 24
$20M
—
Q2 24
$24M
166.7%
Q3 24
$18M
28.8%
Q4 24
$18M
17.1%
Q1 25
$21M
15.3%
Q2 25
$25M
11.8%
Q3 25
$26M
9.1%
Q4 25
$0
0.0%
marketcaparena.com
OpEx Breakdown
R&D
G&A
SG&A
Quarter
R&D
G&A
SG&A
Q1 23
$62M
$16M
—
Q2 23
$69M
$18M
—
Q3 23
$71M
$28M
—
Q4 23
$71M
$47M
—
Q1 24
$71M
—
$81M
Q2 24
$71M
—
$105M
Q3 24
$69M
$108M
—
Q4 24
$26M
—
$141M
Q1 25
$44M
—
$168M
Q2 25
$54M
—
$197M
Q3 25
$174M
$209M
—
Q4 25
$116M
—
$240M
marketcaparena.com
Revenue Segments
Reportable Segment
Quarter
Reportable Segment
Q2 25
$213M
Q3 25
$287M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$113M
$216M
$329M
Q2 23
$77M
$221M
$298M
Q3 23
$62M
$170M
$232M
Q4 23
$100M
$534M
$634M
Q1 24
$623M
$437M
$1.1B
Q2 24
$495M
$563M
$1.1B
Q3 24
$233M
$766M
$999M
Q4 24
$100M
$826M
$926M
Q1 25
$184M
$659M
$843M
Q2 25
$186M
$611M
$797M
Q3 25
$296M
$814M
$1.1B
Q4 25
$199M
$785M
$984M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
18M
+5.5%
Q2 23
18M
+0.7%
Q3 23
18M
+0.9%
Q4 23
20M
+7.0%
Q1 24
20M
+1.2%
Q2 24
21M
+7.0%
Q3 24
22M
+1.6%
Q4 24
22M
+0.8%
Q1 25
22M
+0.7%
Q2 25
22M
+0.5%
Q3 25
22M
+1.2%
Q4 25
22M
-0.2%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
$0
110
FY 15
$0
33
FY 16
$0
8
FY 17
$0
8
FY 18
$0
17
FY 19
$0
29
FY 20
$0
42
FY 21
$0
71
FY 22
$0
92
FY 23
$0
376
FY 24
$341K
528
FY 25
$1M
915
marketcaparena.com